Hepatitis C Virus Elimination by 2030: Conquering Mount Improbable-Reference-Cited by-同舟云学术

Hepatitis C Virus Elimination by 2030: Conquering Mount Improbable

Published:2020-12 Issue:6 Volume:16 Page:254-261
ISSN:2046-2484
Container-title:Clinical Liver Disease
language:en
Short-container-title:Clinical Liver Disease

Author:

Dhiman Radha K.¹²³⁴,Premkumar Madhumita¹^ORCID

Affiliation:

1. Department of Hepatology Postgraduate Institute of Medical Education and Research Chandigarh India

2. Mukh‐Mantri Punjab Hepatitis C Relief Fund Punjab Government Punjab India

3. Ministry of Health and Family Welfare New Delhi India

4. Injection Safety Project, Punjab Government Punjab India

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cld.978

Reference26 articles.

1. World Health Organization.Global Health Sector Strategy on Viral Hepatitis 2016‐2021: towards ending viral hepatitis. WHO/HIV/2016.06. Available at:http://www.who.int/hepatitis/strategy2016-2021/ghss-hep/en/. Accessed June 15 2019.

2. The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013;Stanaway JD;Lancet,2016

3. World Health Organization.Progress report on access to hepatitis C treatment. Focus on overcoming barriers in low‐ and middle‐income countries. WHO/CDS/HIV/18.4. Available at:http://apps.who.int/iris/bitstream/10665/260445/1/WHO-CDS-HIV-18.4-eng.pdf?ua=1. Published March 2018. Accessed June 21 2019.

4. Real‐world cost‐effectiveness of pan‐genotypic Sofosbuvir‐Velpatasvir combination versus genotype dependent directly acting anti‐viral drugs for treatment of hepatitis C patients in the universal coverage scheme of Punjab state in India;Chugh Y;PLoS One,2019

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Differences in HCV Seroprevalence, Clinical Features, and Treatment Outcomes between Female and Male Incarcerated Population: Results from a Matched Cohort Study;Viruses;2023-12-12

2. People who inject drugs: testing and treatment of HIV and HCV;The Lancet Global Health;2023-12

3. Single-molecule-binding studies of antivirals targeting the hepatitis C virus core protein;Journal of Virology;2023-10-31

4. Self-awareness of hepatitis C infection in the United States: A cross-sectional study based on the National Health Nutrition and Examination Survey;PLOS ONE;2023-10-24

5. Risk Factors for Perinatal Transmission of Hepatitis C Virus;Obstetrics & Gynecology;2023-09